Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Fulvestrant in the Era of CDK4/6 Inhibitors for HR+ mBC

Abemaciclib With Hormone Therapy for HR+ mBC

Differences Among CDK4/6 Inhibitors in HR+ mBC

Efficacy of CDK4/6 Inhibitors in HR+ mBC

Biomarkers for CDK4/6 Inhibitors in HR+ mBC

CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer

HR+ Breast Cancer: Updated Results From MONARCH Trials 

Abemaciclib's Value in Treating HR+ Breast Cancer  

HR+ Breast Cancer: Pooled Analysis From MONARCH 2 and 3 

HR+ Breast Cancer: Resistance to Primary Therapy 

Factors in Deciding Treatment for HR+ Breast Cancer 

Heterogeneity of Metastatic HR+ Breast Cancer

Understanding Abemaciclib: A New CDK4/6 Inhibitor

CDK4/6 Inhibitor Combinations for HR+ mBC 

ER+/HER2+ Metastatic Breast Cancer

Future Directions: CDK4/6 Inhibitors in Breast Cancer

Treatment Selection for HR+ mBC

mBC: CDK4/6 Inhibitor Patient Selection/Sequencing

CDK4/6 Inhibitors in Breast Cancer: Ongoing Research

FDA Approval for Abemaciclib

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Breast Cancer

Breast Cancer | Specialty